ARCHIVES

GAO Backs DeVita On Why advances Aren’t Producing Mortality Reduction

This article is from The Cancer Letter archive.

Vol. 14 No. 06 | February 5, 1988

Download PDF Visit The Full Archive

Related Articles

Improved NCI Relations With FDA Cited As Model For Government Accord, Lasagna Committee Says

April 20, 1990

FDA Approves Generic Capecitabine

September 20, 2013

AACR Changes Its Logo— For The Fifth Time Since 2000

July 11, 2014

Report Urges NCI: No Unfunded Mandates for Cancer Centers

October 18, 1996

ASCO Recommends Discussing Pharmacological Prevention

July 26, 2013

Erbitux Plus Radiation, Chemo, Appears To Provide CRs In A Small Phase II Study

February 23, 2007